Oceania · General news · The Advertiser (Adelaide Now)

TrivarX takes key step towards trial of next-gen cancer imaging technology

Published by The Advertiser (Adelaide Now) · Australia 8 h ago

TrivarX has enlisted pharmaceutical specialist Syntro Health to help prepare its Stabl-Im imaging technology for clinical trials starting in 2027.

Read the full article on The Advertiser (Adelaide Now) Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.adelaidenow.com.au)

Also worth reading

Superquiz, Friday, October 23

Superquiz, Friday, October 23

Superquiz, Friday, October 23

Independent Australia

The unshakable enterprise: A practical framework for business preparedness

Wild moment tradies tackle, zip-tie masked axeman after alleged carjacking attempt on Melbourne road

AVer Announces FONE700+ Scalable Ceiling Speakerphone System for Large Hybrid Meeting Spaces